@article{d9d53bc9e3e44df6be432d2a3a58029f,
title = "Farmacogenetica: farmacotherapie aanpassen aan het genotype",
keywords = "acenocoumarol, beta 2 adrenergic receptor stimulating agent, contraceptive agent, coumarin derivative, cytochrome P450 2D6, cytostatic agent, diuretic agent, glibenclamide, glimepiride, glipizide, haloperidol, hydrochlorothiazide, hydroxymethylglutaryl coenzyme A reductase inhibitor, neuroleptic agent, prodrug, sulfonylurea derivative, thioridazine, acute psychosis, allele, biotransformation, dominant gene, drug metabolism, drug monitoring, gene expression, genotype, homozygote, human, intensive care, pharmacogenetics, phenotype, psychiatric diagnosis, recessive gene, short survey, single nucleotide polymorphism",
author = "{Maitland-Van der Zee}, A.H. and {De Boer}, A.",
year = "2003",
month = mar,
day = "1",
language = "Dutch",
volume = "37",
pages = "25--30",
journal = "Geneesmiddelenbulletin",
issn = "0304-4629",
publisher = "Stichting Geneesmiddelenbulletin",
number = "3",
}